The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-methylfuran-2-yl)-6-[3-(pyrrolidine-1-carbonyl)phenyl]pyrimidin-2-amine ID: ALA3735439
PubChem CID: 127036697
Max Phase: Preclinical
Molecular Formula: C20H20N4O2
Molecular Weight: 348.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(-c2cc(-c3cccc(C(=O)N4CCCC4)c3)nc(N)n2)o1
Standard InChI: InChI=1S/C20H20N4O2/c1-13-7-8-18(26-13)17-12-16(22-20(21)23-17)14-5-4-6-15(11-14)19(25)24-9-2-3-10-24/h4-8,11-12H,2-3,9-10H2,1H3,(H2,21,22,23)
Standard InChI Key: JYVLYFJUIUVRCK-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5987 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8991 -0.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1969 -1.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1945 -3.0046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8943 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5964 -3.0004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8924 -4.9525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0351 3.6026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4978 -0.7563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.6404 0.7242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.1086 1.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8544 -0.2701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8472 -1.3816 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.0475 -0.3993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4470 5.2297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9153 5.5365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6607 4.2349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6532 3.1236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
11 13 1 0
3 14 1 0
14 15 2 0
14 16 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 1 0
9 17 1 0
20 22 1 0
16 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 16 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 348.41Molecular Weight (Monoisotopic): 348.1586AlogP: 3.53#Rotatable Bonds: 3Polar Surface Area: 85.25Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.90CX LogP: 2.93CX LogD: 2.93Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.78Np Likeness Score: -1.43
References 1. Robinson SJ, Petzer JP, Terre'Blanche G, Petzer A, van der Walt MM, Bergh JJ, Lourens AC.. (2015) 2-Aminopyrimidines as dual adenosine A1/A2A antagonists., 104 [PMID:26462195 ] [10.1016/j.ejmech.2015.09.035 ]